Company Overview

Update
Founded:
2011
Founders:
Jonathan Lim
Headquarters:
San Diego, CA
IPO:
Went Public on Mar 14, 2014
Stock:
RXDX
Categories:
Health Care, Biotechnology
Description:
Ignyta is a biotechnology company catalyzing personalized medicine in autoimmune diseases.

Detailed Description

Update

Ignyta is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide.

Current Team (7)

Update

Funding Rounds (4) - $70.5M

Update

Board Members and Advisors (2)

Update

Acquisitions (1)

Update

Investors (3)

Update
  • 999044c487372c950ce11f46cc192ec5

    Silicon Valley Bank

    Silicon Valley Bank works with technology, life science, cleantech, venture capital, private...
  • A1be8f303cdfa3880726e736bb88185a

    City Hill Ventures

    City Hill Ventures, LLC is a health care focused investment firm based in San Diego, California,...
  • E60690e0fb89213d15cf73eadb8d8ee8

    Colt Ventures

    Opportunistic investment firm

Offices/Locations (1)

Update
  • Headquarters

    11575 Sorrento Valley Road

    Suite 200

    San Diego, CA 92121

    USA

Images (1)

Update
  • Ec0fc4ea78aab6d67eb9c400bfd11495